All, There might be some truth to why Generex / NGIO might be silent right now. While I don't like it, and it is frustrating, but if they do have a SEC issue because of Covid (why we don't see this with a ton of other companies, I have no idea), and we are not hearing about the IND or the IPO, it does look like the FDA does share information with the SEC and has been doing it since 2004.

So, the question would be, what exactly is going on?

https://www.nixonpeabody.com/-/media/Files/Al...92004.ashx